Korean Reinsurance Company (KRX:003690)

Market Cap	1.82T
Revenue (ttm)	4.43T
Net Income (ttm)	354.81B
Shares Out	176.72M
EPS (ttm)	2,490.74
PE Ratio	4.13
Forward PE	5.84
Dividend	515.00 (4.83%)
Ex-Dividend Date	Apr 1, 2025

Volume	146,480
Average Volume	436,532
Open	10,680
Previous Close	10,600
Day's Range	10,570 - 10,730
52-Week Range	6,500 - 11,690
Beta	0.25
RSI	42.59
Earnings Date	Aug 14, 2025

About Verve Therapeutics

Korean Reinsurance Company, a reinsurance company, provides life and non-life reinsurance products in Korea and internationally. The company offers property insurance products, such as fire, property all risks, inland floater, and museum; engineering insurance products, including contractor’s and erection all risks, machinery, electric equipment, civil engineering completed risk, contractor’s plant and machinery, and comprehensive machinery; marine insurance products comprising hull, cargo, and aviation; and casualty insurance products, such as...

• Industry: Insurance - Reinsurance
• Sector: Financials
• Founded: 1963
• Employees: 438
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003690

Financial Performance

In 2024, KRX:003690's revenue was 4.39 trillion, an increase of 5.91% compared to the previous year's 4.15 trillion. Earnings were 275.37 billion, an increase of 7.34%.